PREMELVAX LIMITED

Active London

Research and experimental development on biotechnology

0 employees website.com
Research and experimental development on biotechnology
P

PREMELVAX LIMITED

Research and experimental development on biotechnology

Founded 8 Feb 2023 Active London, United Kingdom 0 employees website.com
Research and experimental development on biotechnology
Accounts Submitted 28 Nov 2025 Next due 30 Nov 2026 6 months remaining
Confirmation Submitted 7 May 2024 Next due 21 Feb 2025 15 months overdue
Net assets £100 £0 2024 year on year
Total assets £100 £0 2024 year on year
Total Liabilities £0
Charges None No charges registered

Contact & Details

Contact

Registered Address

2 Leman Street London E1W 9US United Kingdom

Full company profile for PREMELVAX LIMITED (14647799), an active company based in London, United Kingdom. Incorporated 8 Feb 2023. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2023–2024)

Cash in Bank

£100.00

Net Assets

£100.00

Total Liabilities

N/A

Turnover

N/A

Employees

N/A

Debt Ratio

N/A

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Michael Peter Hugh FoxDirectorBritishUnited Kingdom848 Feb 2023Active

Shareholders

Shareholders (3)

International Claim Strategies Limited
100.0%
100
Jacek Mackiewicz
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased
Notified 8 Feb 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Michael Peter Hugh Fox

Ceased 8 Feb 2023

Ceased

Professor Andrzej Mackiewicz

Ceased 24 Aug 2023

Ceased

Group Structure

Group Structure

PREMELVAX LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 May 2026GazetteGazette Dissolved Voluntary
17 Feb 2026GazetteGazette Notice Voluntary
10 Feb 2026GazetteGazette Notice Compulsory
10 Feb 2026DissolutionDissolution Application Strike Off Company
28 Nov 2025AccountsAnnual accounts made up to 28 Feb 2025
5 May 2026 Gazette

Gazette Dissolved Voluntary

17 Feb 2026 Gazette

Gazette Notice Voluntary

10 Feb 2026 Gazette

Gazette Notice Compulsory

10 Feb 2026 Dissolution

Dissolution Application Strike Off Company

28 Nov 2025 Accounts

Annual accounts made up to 28 Feb 2025

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 days ago on 5 May 2026

Gazette Notice Voluntary

2 months ago on 17 Feb 2026

Gazette Notice Compulsory

2 months ago on 10 Feb 2026

Dissolution Application Strike Off Company

2 months ago on 10 Feb 2026

Annual accounts made up to 28 Feb 2025

5 months ago on 28 Nov 2025